|
US 11,690,836 B2 |
|
| Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
| James Densmore Copp, Silverthorne, CO (US); Ann W. Newman, Lafayette, IN (US); and Anne Luong, Mississauga (CA) |
| Assigned to AKEBIA THERAPEUTICS, INC., Cambridge, MA (US) |
| Filed by Akebia Therapeutics, Inc., Cambridge, MA (US) |
| Filed on Jun. 15, 2021, as Appl. No. 17/347,700. |
| Application 15/994,348 is a division of application No. 15/608,186, filed on May 30, 2017, granted, now 9,987,262, issued on Jun. 5, 2018. |
| Application 15/608,186 is a division of application No. 14/541,284, filed on Nov. 14, 2014, granted, now 9,701,636, issued on Jul. 11, 2017. |
| Application 17/347,700 is a continuation of application No. 16/786,187, filed on Feb. 10, 2020, granted, now 11,065,237. |
| Application 16/786,187 is a continuation of application No. 16/178,191, filed on Nov. 1, 2018, granted, now 10,596,158, issued on Mar. 24, 2020. |
| Application 16/178,191 is a continuation of application No. 15/994,348, filed on May 31, 2018, granted, now 10,149,842, issued on Dec. 11, 2018. |
| Claims priority of provisional application 61/904,803, filed on Nov. 15, 2013. |
| Prior Publication US 2022/0040159 A1, Feb. 10, 2022 |
| Int. Cl. C07D 213/65 (2006.01); A61K 31/4418 (2006.01); A61K 31/444 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); C07D 213/81 (2006.01); A61K 9/14 (2006.01); C07D 213/803 (2006.01); C07D 221/00 (2006.01) |
